Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Finances

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon May 05, 2023 7:20pm

215 Views

Post# 35434088

RE:RE:RE:RE:RE:RE:Finances

I think at this point, given the CR numbers. TLT will own late stage NMIBC. I'm expecting a JV for that should bring in 9 figures. Enough for them to get a solid Phase 1 for NSCLS off the ground.

Anyone think TLT will fail to get the BTD for this? And an AA afterwards?

Place your bets! :-)

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta